Sobi Acquires Arthrosi Therapeutics for $950 Million
Sobi, a prominent player in the biopharmaceutical industry, has announced its intention to acquire Arthrosi Therapeutics, a biotechnology firm focused on developing gout therapies. The deal is valued at $950…